Printer Friendly

WISCONSIN PHARMACAL CHARTEX-U.S. REALITY PAYMENT DELAYED

 JACKSON, Wis., July 8 /PRNewswire/ -- Wisconsin Pharmacal announced that, consistent with its agreements, the $3,000,000 payment due Chartex International on Aug. 31, 1993, to retain exclusive U.S. rights for the REALITY(R) female condom will be delayed up to six months contingent on U.S. Food and Drug Administration approval of the Chartex manufacturing facility.
 The REALITY female condom was approved by the Food and Drug Administration in May. Shipments to sexually transmitted disease and planned parenthood clinics will begin this month using product manufactured at Wisconsin Pharmacal's limited capacity facility.
 Chartex International, based in London, is the licensor and the worldwide manufacturer of the product. Wisconsin Pharmacal and Chartex are in discussions with FDA to secure approval of the Chartex facility. The company and Chartex are closely working together to expedite FDA's review and inspection of the facility. Once this approval occurs, national commercial distribution may begin.
 REALITY is the first and only female condom approved by FDA, the only product under a woman's control that helps to prevent unintended pregnancy and sexually transmitted disease, including AIDS, and the first of a new class of products approved to help prevent AIDS since the epidemic began more than ten years ago. REALITY provides women with a new option under their control when their partners don't wear a latex male condom. Three U.S. patents have issued for REALITY with the first expiring in the year 2005.
 Wisconsin Pharmacal has the exclusive rights to market REALITY in the U.S., Canada, and Mexico.
 -0- 7/8/93
 /CONTACT: Dr. Mary Ann Leeper, senior vice-president development, 312-280-8541, (REALITY(R) product information); or John A. Wundrock, president & CEO, 414-677-4121, (company information), both of Wisconsin Pharmacal/


CO: Wisconsin Pharmacal ST: Wisconsin IN: MTC SU:

LR -- NY012 -- 9363 07/08/93 09:08 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 8, 1993
Words:302
Previous Article:AMES REPORTS JUNE SALES
Next Article:CERNER CORPORATION ANNOUNCES AGREEMENT TO IMPLEMENT A WIDE ARRAY OF HEALTHCARE NETWORK ARCHITECTURE SYSTEMS AT HOSPITAL IN CHEMNITZ, GERMANY
Topics:


Related Articles
WISCONSIN PHARMACAL COMPANY, INC., FAMILY HEALTH INTERNATIONAL COMPLETE REALITY AGREEMENT
WISCONSIN PHARMACAL REPORTS PROGRESS ON REALITY FEMALE CONDOM
REALITY(R) FEMALE CONDOM FIRST U.S. SHIPMENTS
MAJOR CHICAGO BANK SIGNS AGREEMENT WITH MARKETER OF THE REALITY FEMALE CONDOM
WISCONSIN PHARMACAL COMPANY, INC. REPORTS THIRD QUARTER OPERATING RESULTS
WISCONSIN PHARMACAL COMPANY, INC. REPORTS THIRD QUARTER OPERATING RESULTS
WISCONSIN PHARMACAL RECEIVES ORDER FROM FAMILY HEALTH INTERNATIONAL
WISCONSIN PHARMACAL SIGNS AGREEMENT TO PURCHASE CHARTEX
WISCONSIN PHARMACAL COMPANY SHAREHOLDERS VOTE: TO SELL UNIT; CHANGE NAME TO THE FEMALE HEALTH COMPANY
WISCONSIN PHARMACAL COMPANY, INC. REPORTS FOURTH QUARTER AND FISCAL 1995 OPERATING RESULTS

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters